Clinical Research Directory
Browse clinical research sites, groups, and studies.
CRUZ Tunisia-Multivessel Registry
Sponsor: Sahajanand Medical Technologies Limited
Summary
The primary objective of this registry is to evaluate the safety and clinical performance of the biodegradable polymer-coated Supraflex Cruz Sirolimus-eluting Stent (SES) in an unselected, all-comer patient population with multivessel disease. This population represents daily clinical practice and includes patients requiring coronary revascularization with drug-eluting stents (DES).
Official title: Evaluation of the Safety and Clinical Performance of the Biodegradable Polymer-Coated Sirolimus-Eluting Stent in All-Comer Patients With Multivessel Coronary Artery Disease
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-11-01
Completion Date
2028-05
Last Updated
2025-02-19
Healthy Volunteers
No
Interventions
Supraflex Cruz Sirolimus-eluting Coronary Stent System
Biodegradable polymer-coated, cobalt-chromium sirolimus-eluting coronary stent
Locations (2)
Sahloul Hospital
Sousse, Tunisia
Habib Thameur Hospital
Tunis, Tunisia